Valiant Laboratories Intrinsic Value
VALIANTLAB Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹20.16 | ₹16.13 - ₹24.19 | -70.0% | EPS: ₹0.16, Sector P/E: 22x |
| Book Value Method | asset | ₹106.36 | ₹95.72 - ₹117.00 | +58.3% | Book Value/Share: ₹53.18, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹85.45 | ₹76.91 - ₹94.00 | +27.2% | Revenue/Share: ₹42.73, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹26.88 | ₹24.19 - ₹29.57 | -60.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹26.88 | ₹21.50 - ₹32.26 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹20.16 | ₹18.14 - ₹22.18 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹20.16 | ₹18.14 - ₹22.18 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹20.16 | ₹18.14 - ₹22.18 | -70.0% | EPS: ₹0.16, BVPS: ₹53.18 |
Want to compare with current market value? Check VALIANTLAB share price latest .
Valuation Comparison Chart
VALIANTLAB Intrinsic Value Analysis
What is the intrinsic value of VALIANTLAB?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Valiant Laboratories (VALIANTLAB) is ₹26.88 (median value). With the current market price of ₹67.19, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹20.16 to ₹106.36, indicating ₹20.16 - ₹106.36.
Is VALIANTLAB undervalued or overvalued?
Based on our multi-method analysis, Valiant Laboratories (VALIANTLAB) appears to be trading above calculated value by approximately 60.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.80 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.71 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Asset Turnover Ratio | 0.47x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Valiant Laboratories
Additional stock information and data for VALIANTLAB
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1 Cr | ₹-26 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹2 Cr | ₹-70 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹56 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |